This showed that overall there was not much difference between the wild-type and mutant p53 tumours (regardless of the genomic location, Additional file 2 Figure S2), with few exceptions detected from our differential analysis (Additional file 2 Figure S1). This evidence concerns the gene TP53 and neoplasm.